Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.
about
Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageTargeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunizationSynthetic DNA vaccine strategies against persistent viral infectionsComparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmidsDNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boostDNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12.Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences.Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.Simian immunodeficiency virus DNA vaccine trial in macaques.Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeysImmune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration.Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteersCharacterization and expression of e2 glycoprotein of classical Swine Fever virus in a eukaryotic expression system.Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models.DNA vaccines for emerging infectious diseases: what if?A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.DNA Immunization for HIV Vaccine Development.Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.
P2860
Q24531468-7CFF73FD-05EB-4766-88D8-8CD189201F56Q24670153-919580C1-5C9F-426D-8585-255FF56AB402Q27016078-4AB9C0BD-8268-408E-B7EF-441604E63C08Q33645053-6C30BB38-1BDC-4B25-8F6D-7A994D1ADC52Q33761524-D0532197-053E-43A8-B7C9-5FBDF21860F0Q33783841-05C6BE56-4AD7-4FB1-AA26-7BE00AF98B28Q33785598-5AC46BFC-4FB9-4EF2-8258-32A72ABC3FBEQ33809753-55E377C6-3B9D-48DB-ACE8-A3AAF19DED1FQ33813173-AC1A080D-09DD-438C-81A8-5FF8742DE4A6Q33843297-14DB4C63-1223-4FB7-B98E-2A4C4A070FF1Q33845287-12048300-86FA-4908-81B9-14077BAA8DC6Q34001848-B27F1091-E700-471F-8FBE-3F913FC857B9Q35674907-A739D03D-13B1-41B6-A880-2D5D2F62E564Q35861970-C9189ACF-B240-48F3-895B-07FB3DDA82F6Q35874803-E786B102-452C-45C9-91FC-F12DA4877429Q35895851-38B59CA2-3727-407B-8ADD-1803CA43B737Q36397263-377CF0D6-1A55-4833-9240-A80A089D1E79Q36438213-C28EDFE2-248D-4696-ADE5-678EDC08AD47Q36528901-9E013772-0837-483D-A3F8-02DA6D358CB3Q36550140-6C30D076-347C-4A69-BBD3-58410E6A0AF4Q36647936-4DAB87C0-36ED-418D-ADB8-B8391B947D65Q37062242-07167DAB-790F-4F3B-8D13-5DCCC8271BEAQ37492797-0BF6C910-DEB6-449F-AD9A-F0CF606D78FBQ38581981-F0D7D423-4A13-419B-A673-A9E962C18667Q42554027-573353AC-E96A-413E-B874-77E0FFC6C484
P2860
Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Simian immunodeficiency virus- ...... vaccination of rhesus monkeys.
@ast
Simian immunodeficiency virus- ...... vaccination of rhesus monkeys.
@en
type
label
Simian immunodeficiency virus- ...... vaccination of rhesus monkeys.
@ast
Simian immunodeficiency virus- ...... vaccination of rhesus monkeys.
@en
prefLabel
Simian immunodeficiency virus- ...... vaccination of rhesus monkeys.
@ast
Simian immunodeficiency virus- ...... vaccination of rhesus monkeys.
@en
P2093
P2860
P921
P1433
P1476
Simian immunodeficiency virus- ...... vaccination of rhesus monkeys
@en
P2093
H L Robinson
J I Mullins
N L Letvin
P2860
P304
P407
P577
1996-01-01T00:00:00Z